Richard I. Eisenstadt

Richard I. Eisenstadt discloses dealings in 3 companies, chiefly Altimmune, Inc., Neos Therapeutics, Inc. and Aytu Biopharma, Inc. We count 20 filings; the first trade dates from 25 August 2016 and the latest from 31 January 2024.

No open-market sale appears; the market trades are 3 purchases worth €72k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 13 share grants and 3 option exercises.

In size, the median ticket on the buying side is €22k. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 1 February 2024 came the latest disclosure, a share grant for €20k in Altimmune, Inc. The last insider purchase was made public on 24 March 2023, 1,326 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.